|
08 Dec 2020 |
Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases
|
|
04 Dec 2020 |
Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies
|
|
04 Dec 2020 |
PharmaEngine, Inc. and Sentinel Oncology Limited Enter into an Exclusive Collaboration and License Agreement for SOL-578, a Chk1 inhibitor
|
|
03 Dec 2020 |
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
|
|
03 Dec 2020 |
Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation
|
|
02 Dec 2020 |
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
|
|
01 Dec 2020 |
Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
|
|
01 Dec 2020 |
Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies
|
|
01 Dec 2020 |
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
|
|
01 Dec 2020 |
Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
|
|
28 Nov 2020 |
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
|
|
23 Nov 2020 |
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies
|
|
23 Nov 2020 |
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb
|
|
23 Nov 2020 |
Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology
|
|
23 Nov 2020 |
Merck to Acquire OncoImmune
|
|
20 Nov 2020 |
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
|
|
19 Nov 2020 |
ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
|
|
19 Nov 2020 |
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
|
|
18 Nov 2020 |
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
|
|
16 Nov 2020 |
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
|
|
13 Nov 2020 |
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
|
|
12 Nov 2020 |
MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
|
|
09 Nov 2020 |
Infinity Pharmaceuticals Presents New MARIO-1 Phase 1/1b Clinical Data at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
|
|
06 Nov 2020 |
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
|
|
06 Nov 2020 |
Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies
|
